VJOncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology.
Our goal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals, worldwide, on a range of innovative digital media – including video and blog formats.
VJOncology content is led by an editorial board of highly respected thought leaders with a combined expertise that spans the spectrum of cancers. All content is created and published under the guidance of this board of world-leading experts.
SunRISe-4: первичные и биомаркерные результаты применения TAR-200 и цетрелимаба при ИРМП
ASPEN: активное наблюдение против хирургического вмешательства при небольших нефункционирующих па...
Определение биомаркеров в терапии первой линии мскПКР в исследовании COSMIC 313
Диварасиб в монотерапии проявляет активность в солидных опухолях KRAS G12Cm
Хидамид плюс торипалимаб демонстрирует многообещающие результаты при запущенной саркоме
Обновления в отношении применения и оценки ингибиторов контрольных точек при раке желудка: рекоме...
LenCabo: ленватиниб + эверолимус улучшает ВБП по сравнению с кабозантинибом при метастатическом с...
ESMO 2025: прорывные исследования ADC при тройном раке молочной железы и HER2+ раке молочной железы
Чего ожидать от конференции ESMO 2025 в области рака мочевыводящих путей
Liver cancer awareness month: evolving strategies in immunotherapy and targeted treatment
Challenges and opportunities in cerebrospinal fluid liquid biopsies in brain tumors
FRONT-BRAF: 1L IO +/- chemo vs BRAF + MEKi in BRAFV600E-m mNSCLC
From cold tumors to hot targets: immunotherapy advances in sarcoma treatment
End points for the next-generation bladder-sparing perioperative trials for patients with MIBC
NutriCare: nutritional support to optimize treatment intensity in NSCLC
Dual checkpoint blockade in NSCLC: insights from meta-analysis
Balancing the benefits and toxicity of IO intensification in lung cancer
New treatment strategies for oligo-progressive non-small cell lung cancer
Proton beam therapy in lung cancer with interstitial lung disease
Safety and efficacy outcomes of SMART-based SABR in ultracentral NSCLC
Biomarkers of ICI response in oncogene-negative never-smoker NSCLC
PACE: ctDNA landscape after CDK4/6 inhibitor progression for metastatic HR+/HER2- breast cancer
ROAR-LCT: supportive care strategies for older adults with thoracic cancer
Identifying supportive care needs for patients with lung cancer
The current state of ADC biomarker testing in India
What does the future hold for ctDNA testing in lung cancer?
Rolling out ctDNA ‘blood-first’ testing for lung cancer in England
Addressing gaps In lung cancer screening in LMICs
Personalized treatment strategies based on smoking history in lung cancer
Investigating lung cancer outcomes in smokers receiving immunotherapy